First Time Loading...
N

Nanjing Vazyme Biotech Co Ltd
SSE:688105

Watchlist Manager
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Watchlist
Price: 24.93 CNY -1.89%
Updated: May 17, 2024

Nanjing Vazyme Biotech Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nanjing Vazyme Biotech Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
N
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Income from Continuing Operations
-¥72.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Income from Continuing Operations
-¥6.7B
CAGR 3-Years
16%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Income from Continuing Operations
-¥1B
CAGR 3-Years
-1%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Income from Continuing Operations
¥1.2B
CAGR 3-Years
22%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Income from Continuing Operations
¥7.5B
CAGR 3-Years
26%
CAGR 5-Years
35%
CAGR 10-Years
50%
Imeik Technology Development Co Ltd
SZSE:300896
Income from Continuing Operations
¥1.3B
CAGR 3-Years
62%
CAGR 5-Years
75%
CAGR 10-Years
N/A

See Also

What is Nanjing Vazyme Biotech Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
-72.9m CNY

Based on the financial report for Dec 31, 2023, Nanjing Vazyme Biotech Co Ltd's Income from Continuing Operations amounts to -72.9m CNY.